The Cross-over of Anticancer Agents with Osteoclast Activities
Journal:
Current Cancer Therapy Reviews
Volume:
7
Page:
290-302
Author(s):
Henning M. Schramm
Radiation Therapy in the Early 21st Century: Technological Advances
Journal:
Current Cancer Therapy Reviews
Volume:
7
Page:
303-318
Author(s):
Milad Enferadi, Mahdi Sadeghi and Alireza Shirazi
Ceramide-Based Therapeutics for the Treatment of Cancer
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
11
Page:
911-919
Author(s):
Brian M. Barth, Myles C. Cabot and Mark Kester
Anticipation in Lynch Syndrome: Where We Are Where We Go
Journal:
Current Genomics
Volume:
12
Page:
451-465
Author(s):
Cristina Bozzao, Patrizia Lastella and Alessandro Stella
Aberrant DNA Methylation and Prostate Cancer
Journal:
Current Genomics
Volume:
12
Page:
486-505
Author(s):
Sunipa Majumdar, Eric Buckles, John Estrada and Shahriar Koochekpour
Editorial [Hot Topic: Overview of Antiangiogenic Therapies in Hematological Malignancies (Guest Editor: D. Ribatti)]
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
995-996
Author(s):
D. Ribatti
Emerging Therapies Targeting Tumor Vasculature in Multiple Myeloma and other Hematologic and Solid Malignancies
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
1005-1024
Author(s):
K. Podar and K. C. Anderson
Clinical Experience with Antiangiogenic Therapy in Leukemia
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
1053-1068
Author(s):
J. Wellbrock and W. Fiedler
EphA2-Dependent Molecular Targeting Therapy for Malignant Tumors
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
1082-1097
Author(s):
RONG Biao-xue, CAI Xi-guang, YANG Shuan-ying, LI Wei and MING Zong-juan
Prodrugs for Targeted Tumor Therapies: Recent Developments in ADEPT, GDEPT and PMT
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
3527-3547
Author(s):
Lutz F. Tietze and Kianga Schmuck